HK Stock Market Move | CSPC PHARMA (01093) rose more than 3%. Net profit fell by 10% year-on-year. Annual dividends increased by 11.5% year-on-year.

CSPC PHARMA (01093) rises more than 3%, with an increase of 3.48% to HK$8.62 by the time of publication, with a trading volume of HK$687 million. In terms of news, CSPC PHARMA released its 2025 annual performance at noon today, with a group total revenue of RMB 26.006 billion, a decrease of 10.4% year-on-year; shareholders' attributable surplus was RMB 3.882 billion, a decrease of 10.3%; basic earnings per share were 33.98 cents. It is worth noting that the board of directors has recommended a final dividend of HK$0.15 per share for the end of 2025. Together with the interim dividend of HK$0.14 per share, the total dividend for 2025 is HK$0.29 per share, an increase of 11.5% from 2024. The announcement also stated that, in terms of business expansion, since the beginning of 2025, the group has completed 5 external authorizations with a total contract amount of US$28.21 billion, fully demonstrating the group's international innovation capability and technical strength, significantly enhancing the group's international reputation and industry influence.